Coeptis Therapeutics (COEP) Stock Price
$8.23 0%
to add to portfolio
AI Score
-
Alternative
0 -
Fundamental
7 -
Technical
6
Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.
Sign up to get access to more historical data and insights on Coeptis Therapeutics, AI stock picks, stock alerts and much more.
COEP AI Stock Analysis
AI stock analysis for COEP is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Coeptis Therapeutics (COEP) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
Coeptis Therapeutics (COEP) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Coeptis Therapeutics (COEP), currently trading at $8.23, will... Sign up to access price prediction.
Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.
About COEP
-
Coeptis Therapeutics, Inc.
-
Symbol
COEP
-
Market
PNK
-
Industry
Biotechnology
-
Market Cap
28.9M
Similar Stocks
No similar companies found.
News
COEP Alternative Data
Web Traffic
Coeptis Therapeutics receives an estimated 1101 monthly visitors to coeptistx.com.
-
Web Traffic
1101
-
Change from Previous Month
26.9%
-
3 Month Change
55.7%
-
YoY Change
55.7%
Twitter Followers
Coeptis Therapeutics has 1,053 Twitter Followers on its main Twitter (also known as X) account, which is down by -21.9% over the last month.
-
Twitter Followers
1053
-
Daily Change
1.1%
-
1 Month Change
21.9%
-
3 Month Change
23.5%
Job Postings
Coeptis Therapeutics currenly has an estimated 0 open job postings.
-
Job Postings
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
LinkedIn Employees
According to LinkedIn, Coeptis Therapeutics has 5 employees.
-
LinkedIn Employees
5
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
28.6%
LinkedIn Followers
2,097 are following Coeptis Therapeutics on LinkedIn.
-
LinkedIn Followers
2097
-
1 Month Change
0%
News Mentions
Coeptis Therapeutics was mentioned 0 times in the news yesterday.
-
News Mentions
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
Reddit Mentions
Coeptis Therapeutics has been mentioned an estimated 2 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
2
-
Daily Change
100%
-
1 Month Change
0%
-
3 Month Change
0%
COEP Financials
COEP Key Metrics
-
Total Revenue
$1.9M
-
Net Income
-$1.9M
-
Earnings per Share
$4.09
-
Free cash flow
-$1.4M
-
EBITDA
-$4.5M
-
EBITDA Ratio
-2.41703
-
Total Assets
$8.9M
COEP 2-year Revenue & Income
COEP 2-year Free Cash Flow
COEP Technicals
COEP SMA
COEP RSI
FAQ
What's the current price of Coeptis Therapeutics (COEP) Stock?
The price of an Coeptis Therapeutics (COEP) share is $8.23.
What's the market cap of Coeptis Therapeutics?
The current market cap of Coeptis Therapeutics is 28.9M.
Should I buy or sell COEP?
Coeptis Therapeutics shows several positive indicators, but they aren’t strong enough to warrant a buy recommendation. At its current price, Coeptis Therapeutics is better viewed as a hold or accumulate position while waiting for further developments.
Is Coeptis Therapeutics a good investment?
The current analysis of Coeptis Therapeutics' fundamentals, technical aspects, and alternative data insights indicates a neutral outlook on the stock. While there are promising elements in Coeptis Therapeutics' portfolio, the presence of equal risks and opportunities suggests that it might not drive significant gains or losses at this moment.
Is now a good time to buy Coeptis Therapeutics (COEP) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, the outlook for Coeptis Therapeutics stock is currently neutral, suggesting a cautious approach might be wise.
What are some stocks similar to Coeptis Therapeutics (COEP) that investors often compare it to?
There are no similar stocks listed for comparison with Coeptis Therapeutics (COEP).
What is the forecast for Coeptis Therapeutics' stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Coeptis Therapeutics' stock price to be around $7.97 in 2026. Starting from the current price of $8.23, this represents a 3.1% change in price, indicating a neutral outlook for the stock.
How to buy Coeptis Therapeutics (COEP) Stock?
Coeptis Therapeutics stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Coeptis Therapeutics shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.